doi: 10.1542/peds.2013-3524.Bläser A, Pulzer F, Knüpfer M, Robel-Tillig E, Vogtmann C, Nickel P, Kiess W.Klin Padiatr.
Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, Tibboel D, Mosca F.Pharmacotherapy.
doi: 10.1542/peds.2013-3524.Bläser A, Pulzer F, Knüpfer M, Robel-Tillig E, Vogtmann C, Nickel P, Kiess W.Klin Padiatr.
Substance abuse during pregnancy is on the rise, especially opioids, both prescribed and illicit, resulting in a hidden epidemic of neonatal abstinence syndrome (NAS). A new management model called eat, sleep, and console, based on the basic functioning of the infant, standardized non-pharmacological care, and an increased in the involvement of the family in the care of the baby, is showing promising results, and may even avoid the need for pharmacological therapy. Haddad PM, Pal BR, Clarke P, Wieck A, Sridhiran S. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?. Clipboard, Search History, and several other advanced features are temporarily unavailable. Perinatal cerebral infarction and maternal cocaine use. Neonatal aspects.
Pharmacology review: drug therapy and breastfeeding: antidepressants, antipsychotics, antimanics, and sedatives.
Wagner CL, Katikaneni LD, Cox TH, Ryan RM. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. This course will help you gain a better understanding of the epidemiology, pathophysiology, clinical presentation, toxicology (including drug-drug interactions), assessment, and treatment of neonatal abstinence syndrome (NAS). Clipboard, Search History, and several other advanced features are temporarily unavailable. The impact of prenatal drug exposure on the neonate. COVID-19 is an emerging, rapidly evolving situation. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
The diagnosis is through a combination of accurate maternal history and neonatal clinical features, with or without biological testing. Ter Horst PG, Jansman FG, van Lingen RA, Smit JP, de Jong-van den Berg LT, Brouwers JR. Pharmacological aspects of neonatal antidepressant withdrawal. Young ME, Hager SJ, Spurlock D Jr. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. Smoking during pregnancy and newborn neurobehavior. The predominant symptoms include central nervous system (CNS), gastrointestinal … A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. neonatal abstinence syndrome is . Treatment strategies for drug-exposed neonates. Jones HE, Heil SH, Baewert A, et al. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Bence C, Bonord A, Rebillard C, et al. [Guideline] Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Most illicit drugs cause an addiction in the mother and dependence in the infant. Infants born to narcotic dependent mothers: physical growth patterns in the first 12 months of life.
Anand KJ, Campbell-Yeo M. Consequences of prenatal opioid use for newborns. © 2020 American College of Clinical Pharmacy Neonatal abstinence syndrome (NAS) is often a multisystem disorder that frequently involves the CNS, gastrointestinal (GI) system, autonomic system, and respiratory system. Management of NAS must also address maternal issues such as co-existing mental illness, intimate partner violence, and limited health care access, to maintain the mother-infant relationship that is necessary for the normal development of the infant. 2018 Nov 22;4(1):47. doi: 10.1038/s41572-018-0045-0. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Unable to load your delegates due to an errorIn: StatPearls [Internet]. Substance use among pregnant women is a major public health issue. July 2013. McKnight S, Coo H, Davies G, Holmes B, Newman A, Newton L, et al. Neonatal withdrawal syndrome, generically termed neonatal abstinence syndrome (NAS), is a complex disorder.
Grim K, Harrison TE, Wilder RT.
2001
/viewarticle/936023
Pritham UA. June 2, 2005. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. Heier LA, Carpanzano CR, Mast J, Brill PW, Winchester P, Deck MD.
Available at Irner TB, Teasdale TW, Nielsen T, Vedal S, Olofsson M. Substance use during pregnancy and postnatal outcomes.
Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome. (Optional) Please enable it to take advantage of the complete set of features! Phenobarbital, despite its lack of effect on gastrointestinal symptoms and unfavorable pharmacologic features, has been identified as a second‐line agent to be used in infants unresponsive to opiates. Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy. Gray KA, Day NL, Leech S, Richardson GA. Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age.